SCHEMBL366483

SCHEMBL366483

COC(=O)c1c2ccccc2n2cc(C=C[S+](C)[O-])ccc12

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 4/20 0.40
KMT2A Q03164 7/20 0.39
MEN1 O00255 4/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 2/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
F2 P00734 1/20 0.37
PLAU P00749 1/20 0.37
ELANE P08246 1/20 0.37
THRB P10828 1/20 0.37
MAPT P10636 3/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366484 0.82 MAPT (0.42) KMT2AMEN1LMNASMN1; SMN2GAA
SCHEMBL366482 0.82 MAPT (0.42) KMT2AMEN1LMNASMN1; SMN2GAA
SCHEMBL366348 0.82 NR4A2 (0.47) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL364533 0.80 NR4A2 (0.45) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL367527 0.75 NR4A2 (0.41) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL364931 0.75 NR4A2 (0.50) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL364927 0.75 SRC (0.51) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL365565 0.74 KMT2A (0.52) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL365826 0.73 KMT2A (0.48) NR4A2KMT2AMEN1LMNASMN1; SMN2
SCHEMBL365901 0.73 NR4A2 (0.39) NR4A2KMT2AMEN1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007007-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed